- PROFESSOR Neuroscience
- PROFESSOR Geriatrics and Palliative Medicine
- PROFESSOR Medicine, Endocrinology, Diabetes and Bone Disease
Ph.D., University of Southern California
ResearchSpecific Clinical/Research Interest:
Aging; obesity; diabetes; Alzheimer's disease; life extension; dietary restriction;
Current Students: Esther Kim (NEU); Cesar Moreno(NEU); and Elizabeth Schwartz (NEU)
Research Personnel: Instructor: Fumiko Isoda
Our laboratory studies the molecular basis of aging and age-related diseases, especially metabolic diseases such as obesity and diabetes, and related neurodegenerative diseases. Focusing on the interface between metabolic signals and the neurons that sense those signals and regulate metabolic processes, we have discovered several key molecular pathways that regulate energy balance and glucose homeostasis; impairments in these pathways constitute the main single-gene causes of obesity and diabetes in humans. We have extended discoveries in mammalian systems to the nematode C. elegans, discovering a transcriptional complex that mediates the protective effects of dietary restriction to increase lifespan and protect against age-related diseases, including Alzheimer-type pathology. Pharmacological activation of this pathway increases lifespan and protects against neurodegenerative diseases, and the same complex predicts lifespan and obesity in mice.
Summary of Research Studies:
Our laboratory uses histological, behavioral, electrophysiological, and molecular, methods (including DNA microarrays and RNA interference) to assess the basic mechanisms by which hypothalamic neurons sense and regulate metabolic state (including body weight and food intake), and how these mechanisms are impaired in metabolic diseases and during aging. A driving question of our laboratory is what may be called the metabolic mystery. This refers to the fascinating phenomenon that obesity is a risk factor for most age-related diseases and indeed for mortality, and conversely dietary restriction appears to slow down the aging process and extend maximum lifespan. Considering that almost all major pathologies are influenced by caloric intake, the mechanisms underlying the metabolic mystery may be considered among the most compelling in biomedical science. We really don't understand why caloric intake should lead to diseases, but many lines of evidence suggest neuroendocrine mech! anisms. We have begun to study the nature of the hypothalamic neurons which are sensitive to nutrition and which in turn regulate metabolic state, and we have thus begun to define a "nutritional field" of neurons which contain overlapping domains sensitive to different nutrients and which regulate different aspects of metabolism. Of particular interest is that the maximum overlap of these nutritional stimulation (e.g., glucose and leptin) may occur within the POMC neurons, which we now believe play a critical role in regulating metabolism. This is particularly interesting because the POMC neurons are among the most sensitive to decline during aging. To begin to directly test the role of specific gene products in the development of obesity, diabetes, and aging, we have now produced several lines of transgenic mice that overexpress leptin, POMC, insulin, and glucokinase specifically in the brain, and we are now assessing the effects of these transgenes in obesity, diabetes, an! d aging. For example, we have now shown that transgenic enhan! cement of neuronal POMC will completely correct the diabetes and other impairments in genetically obese mice. These studies have led to discovery of a new class of anti-obesity drugs that we are now studying. A new direction in our laboratory involves examining function of metabolic genes we have discovered using microarrays using RNA interference protocols in mice and in C. elegans. Using high-throughput RNAi screening methods we have discovered over 20 novel genes that regulate obesity in C. elegans. Using a similar approach we have also discovered a transcriptional complex that mediates the protective effects of dietary restriction to increase lifespan and protect against age-related diseases, including Alzheimer-type pathology and diabetic complications. Pharmacological activation of this pathway increases lifespan and protects against neurodegenerative diseases, and the same complex predicts lifespan and obesity in mice. We have now also developed novel high-throughput! methods to discover novel anti-obesity and anti-diabetes drugs, and have discovered over 20 drugs in each class so far.
Visit Dr. Charles Mobbs's Aging and Metabolism Lab for more information.
Zhang M, Poplawski M, Yen K, Cheng H, Bloss E, Zhu X, Patel H, Mobbs CV. Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling. PLoS Biology 2009 Nov; 7(11).
Yen K, Mobbs CV. Isoforms play no role in lifespan in ad lib or dietary restricted conditions, but ablation of SOD-1 reduces life extension by cold. Mech. Age. and Dev 2008; In Press.
Yen K, Steinsaltz D, Mobbs CV. Validated analysis of mortality rates demonstrates distinct genetic mechanisms that influence lifespan. Exp Gerontol 2008 Sep 14;.
Yen K, Mobbs CV. Chemosensory and caloric mechanisms influence distinct components of mortality rate. Exp Gerontol 2008 Aug 28;.
Cheng H, Isoda F, Belsham D, Mobbs CV. Inhibition of AgRP expression by glucose in a clonal hypothalamic neuronal cell line is mediated by glycolysis, not oxidative phosphorylation. Endocrinology 2008; 149(2): 703-710.
Yang XJ, Mastaitis J, Mizuno T, Mobbs C. Glucokinase regulates reproductive function, glucocorticoid secretion, food intake, and hypothalamic gene expression. Endocrinology 2007; 104(7): 2501-2506.
Mizuno TM, Roberts J, Kelley K, Mobbs CV. Transgenic neuronal expression of proopiomelanocortin corrects insulin resistance in leptin-deficient but not diet-induced obesity . Diabetes 2003 Nov; 52(11): 2675-2683.
Mobbs CV. Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci. 2002; 7;3(1): 18.
Mizuno TM, Kleopoulos SP, Bergen H, Roberts JL, Priest CA, Mobbs CV. Rapid Communication: Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998; 47: 294-297.
Mizuno TM, Bergen H, Funabashi T, Kleopoulos SP, Zhong YG, Bauman WA, Mobbs CV. Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet- induced) and genetic (yellow agouti) obesity. Proc Natl Acad Sci U S A 1996; 93(8): 3434-3438.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Mobbs did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Hess CSM Building Floor 9th Floor Room 119
1470 Madison Avenue
New York, NY 10029
Hess CSM Building Floor 9th Floor Room 119
1470 Madison Avenue
New York, NY 10029